PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.45
+5.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.16x
- Price / sales
- —
- Price / cash flow
- -1.21x
Enterprise value
- Enterprise value
- -$23.8M
- EV / sales
- —
- EV / EBITDA
- 4.36x
- EV / EBIT
- 3.40x
- Market cap
- $4.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jul 1, 2026